BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16459066)

  • 1. The role of stroma in immune recognition and destruction of well-established solid tumors.
    Yu P; Rowley DA; Fu YX; Schreiber H
    Curr Opin Immunol; 2006 Apr; 18(2):226-31. PubMed ID: 16459066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the stroma by T cells to limit tumor growth.
    Zhang B
    Cancer Res; 2008 Dec; 68(23):9570-3. PubMed ID: 19047130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
    Görgün G; Anderson KC
    Immunotherapy; 2011 Oct; 3(10):1253-64. PubMed ID: 21995575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cells as mediators of solid tumor metastasis.
    DeNardo DG; Johansson M; Coussens LM
    Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
    Liu A; Hu P; Khawli LA; Epstein AL
    J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
    Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equilibrium between host and cancer caused by effector T cells killing tumor stroma.
    Zhang B; Zhang Y; Bowerman NA; Schietinger A; Fu YX; Kranz DM; Rowley DA; Schreiber H
    Cancer Res; 2008 Mar; 68(5):1563-71. PubMed ID: 18316622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
    Gordon EM; Chan MT; Geraldino N; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Hall FL
    Int J Oncol; 2007 Jun; 30(6):1297-307. PubMed ID: 17487349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunologists and cancer biologists: why we didn't talk then but need to now.
    Prendergast GC; Jaffee EM
    Cancer Res; 2007 Apr; 67(8):3500-4. PubMed ID: 17413003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts.
    Tzukerman M; Rosenberg T; Reiter I; Ben-Eliezer S; Denkberg G; Coleman R; Reiter Y; Skorecki K
    Cancer Res; 2006 Apr; 66(7):3792-801. PubMed ID: 16585206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
    de Souza AP; Bonorino C
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment: the role of the tumor stroma in cancer.
    Li H; Fan X; Houghton J
    J Cell Biochem; 2007 Jul; 101(4):805-15. PubMed ID: 17226777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium.
    Jacobsen BM; Harrell JC; Jedlicka P; Borges VF; Varella-Garcia M; Horwitz KB
    Cancer Res; 2006 Aug; 66(16):8274-9. PubMed ID: 16912208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology and breast cancer: therapeutic cancer vaccines.
    Curigliano G; Rescigno M; Goldhirsch A
    Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.